We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+30.64%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$1.86B
AUM Growth
+$450M
Cap. Flow
+$78M
Cap. Flow %
4.19%
Top 10 Hldgs %
28.29%
Holding
210
New
17
Increased
81
Reduced
91
Closed
21

Top Buys

Rank Stock Value
1
OSW icon
OneSpaWorld
OSW
+$30.6M
2
EHTH icon
eHealth
EHTH
+$25.4M
3
HQY icon
HealthEquity
HQY
+$18.9M
4
ETSY icon
Etsy
ETSY
+$16.5M
5
THRM icon
Gentherm
THRM
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 35.55%
2 Healthcare 19.5%
3 Industrials 14.37%
4 Consumer Discretionary 10.01%
5 Real Estate 5.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLNT
176
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$813K 0.04%
229,030
+166,831
+268% +$905K
ENSV
177
DELISTED
Enservco Corp.
ENSV
$808K 0.04%
101,685
-5,506
-5% -$40.3K
JNCE
178
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$778K 0.04%
125,533
-5,860
-4% -$28.3K
MIXT
179
DELISTED
MIX TELEMATICS LIMITED
MIXT
$749K 0.04%
+44,959
New +$772K
ANGI icon
180
Angi Inc
ANGI
$196M
$686K 0.04%
4,441
+943
+27% +$153K
JRVR icon
181
James River Group Holdings
JRVR
$217M
$617K 0.03%
15,385
-42,671
-73% -$1.67M
LYV icon
182
Live Nation Entertainment
LYV
$42.1B
$597K 0.03%
9,393
-1,083
-10% -$61.4K
NBRV
183
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$565K 0.03%
925
-45
-5% -$24.5K
VIVE
184
DELISTED
VIVEVE MED INC
VIVE
$559K 0.03%
595
-29
-5% -$30.8K
FBRX icon
185
Forte Biosciences
FBRX
$1.57B
$431K 0.02%
106
-5
-5% -$19.3K
NVTR
186
DELISTED
Nuvectra Corporation Common Stock
NVTR
$420K 0.02%
38,150
-36,680
-49% -$495K
EVBG
187
DELISTED
Everbridge, Inc. Common Stock
EVBG
$236K 0.01%
+3,148
New +$206K
MGPI icon
188
MGP Ingredients
MGPI
$375M
$225K 0.01%
2,915
-1,266
-30% -$92.4K
GWR
189
DELISTED
Genesee & Wyoming Inc.
GWR
$218K 0.01%
2,500
-13,500
-84% -$1.09M
AXGN icon
190
Axogen
AXGN
$2.5B
-23,050
Closed -$471K
ESPR
191
DELISTED
Esperion Therapeutics
ESPR
-108,200
Closed -$4.98M
FCFS icon
192
FirstCash
FCFS
$8.78B
-2,810
Closed -$203K
GTN icon
193
Gray Television
GTN
$552M
-94,000
Closed -$1.39M
HAE icon
194
Haemonetics
HAE
$4B
-2,550
Closed -$255K
IONS icon
195
Ionis Pharmaceuticals
IONS
$9.4B
-4,316
Closed -$233K
IRWD icon
196
Ironwood Pharmaceuticals
IRWD
$714M
-472,315
Closed -$4.1M
LRMR icon
197
Larimar Therapeutics
LRMR
$432M
-17,751
Closed -$1.05M
NEOG icon
198
Neogen
NEOG
$2.5B
-7,066
Closed -$201K
NXST icon
199
Nexstar Media Group
NXST
$5.97B
-30,607
Closed -$2.41M
PCRX icon
200
Pacira BioSciences
PCRX
$997M
-133,693
Closed -$5.75M

Similar funds

Granahan Investment Management's Q1 2019 Portfolio in Review

As of Q1 2019, Granahan Investment Management held 210 positions worth $1.86B, up 32% from $1.41B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Granahan Investment Management deployed $78M of net new capital in Q1 2019, opening 17 new positions and adding to 81 existing holdings. Its largest new stake was OneSpaWorld: 2,358,040 shares worth $32.2M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Edgio, Inc. Common Stock, an estimated $13.5M trimmed.

  • Granahan Investment Management's largest Q1 2019 buy was OneSpaWorld: 2,358,040 shares worth $32.2M.
  • Granahan Investment Management added most to Etsy in Q1 2019, an estimated $16.5M increase.
  • Granahan Investment Management's biggest Q1 2019 reduction was Edgio, Inc. Common Stock, cutting an estimated $13.5M.
  • Granahan Investment Management fully exited WW International in Q1 2019, selling an estimated $23.2M.
  • Granahan Investment Management's ten largest holdings make up 28% of its $1.86B portfolio in Q1 2019.
  • Granahan Investment Management opened 17 new positions and closed 21 in Q1 2019.
  • Granahan Investment Management's portfolio value rose 32% quarter-over-quarter to $1.86B.

Based on Granahan Investment Management's 13F filing for Q1 2019, filed 14 May 2019.